Reveal Explorer

Adaptive AI‑Driven real‑time Diagnostic Solutions

Real-Time Insights for Smarter Decisions

"From detecting brain and breast cancer cells to monitoring biofluids — precision you can trust."

Built on the Reveal platform and trusted by renowned scientists, surgeons, and hospitals across 3 continents, Exclaro’s technology was designed to solve the most complex challenges, like detecting cancer cells in the brain and breast tissue in real time.

With over 9 years of research and 180+ peer-reviewed publications, we’ve extended this expertise to biofluid analysis, food safety, and industrial monitoring.

If we can detect the smallest anomalies in critical organs, imagine what we can do for everyday diagnostics.

Visit the Website

Our TechnologiES

Reveal Explorer (EXCLARO)

Developed by Exclaro and powered by Reveal Lume Lab and strategic partners, Reveal Explorer is an advanced platform for real-time biofluid, solids tissues and process analysis. Built on 9 years of research from Reveal , it excels in detecting complex biomarkers for cancer, HSV, and chronic diseases, supporting both early detection and personalized healthcare. This platform not only demonstrates exceptional performance in detecting cancer cells but has also expanded into broader applications, such as veterinary diagnostics, food safety, industrial monitoring, and environmental surveillance. Whether it’s safeguarding animal health, ensuring product safety, or optimizing industrial workflows, Reveal Explorer also enables monitoring in remote and extreme locations, setting a new benchmark in precision, versatility, and adaptability.

REVEAL A.I (A New Era of Molecular Data Intelligence)

Reveal A.I decodes what others can’t. By analyzing rich molecular spectra and biomarkers that hold the key to understanding physico-chemical changes, we create an entirely new data source — unique, essential, and transformative.

Our proprietary SaaS platform translates complex data into actionable insights for human and animal health, enabling pharmaceutical companies to refine and personalize treatments. From pandemic prevention to therapeutic optimization and global security, Reveal A.I supports smarter decisions with data that drives innovation across multiple fields.

Reveal Diagnostic (Medical Guidance System)

REVEAL SENTRY™ (Sentinel) is an innovative surgical guidance system designed to detect cancerous tissue margins in real time during operations. By integrating Raman spectroscopy with AI, it distinguishes between healthy and cancerous tissues with unmatched precision. Recognized as a Breakthrough Device, it outperforms existing technologies for detecting multiple cancers, including breast cancer, significantly reducing reoperations. Reveal Diagnostic also includes SENTRY Biofluid, capable of detecting cancers like lung and prostate cancer through biofluid analysis. Trusted globally with over 20,000 measurements and 180 peer-reviewed publications, Reveal Diagnostic is setting new standards in oncology surgery and precision diagnostics.

Unleashing the Power of Real‑Time Molecular Insights

Faster Than Ever

Detect critical changes in real time, from cancer cells to environmental anomalies, with results in seconds.
A Unique Data Source

Reveal A.I builds an unprecedented molecular database − rich in biomarkers, spectra, and physico‑chemical patterns − that drives smarter therapeutic decisions and innovations.
Cost‑Effective Precision

Affordable diagnostics that outperform traditional solutions, making high‑impact testing accessible everywhere.
Non‑Invasive & Multi‑Purpose

Analyze biofluids, environmental samples, and industrial liquids without invasive procedures or sample preparation.
Proactive Health Monitoring

Early detection of diseases, including cancer, chronic conditions, and viral infections like HSV, preventing crises before they occur.
Remote-Ready Technology

Deployable in remote or extreme environments, ensuring vital data collection and diagnostics anywhere.
AI-Powered Evolution

Our proprietary SaaS platform continuously integrates new capabilities and biomarkers via simple software updates, adapting to emerging needs.
Validated by Global Experts

Backed by over 9 years of research and 180+ peer-reviewed publications, trusted by hospitals, universities, and government institutions across three continents.
Multi-Domain Impact

From precision surgery to pandemic prevention, Reveal Explorer and Reveal SENTRY™ support smarter decisions in healthcare, animal health, food safety, and industrial monitoring.